Induction of Matrix Metalloproteinase 9 Expression in Breast Carcinoma Cells by a Soluble Factor from Fibroblasts

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 1996 May 1

PMID 8674273

Citations 6

Authors

B P Himelstein

R J Muschel

Affiliations

Soon will be listed here.

Abstract

Tumor-stromal interactions appear to play an important role in the induction of metalloproteinase expression in malignant tumors. We describe a tissue culture system in which expression of MMP-9 (gelatinase B or the 92 kDa type IV collagenase/gelatinase) was induced by co-cultivation of fibroblasts with breast cancer cell lines. While neither the breast cancer cells nor the normal rat embryo fibroblasts made MMP-9 alone in culture, human MMP-9 was made in the co-cultures. The MMP-9 was secreted in a latent form. The induction occurred at least in part through increases in the MMP-9 mRNA levels in the breast cancer cells. These increases did not appear to require protein synthesis. Conditioned medium from the fibroblasts could duplicate the induction of MMP-9 in the breast cancer cell lines. The active factor in the medium was inactivated by heat or by trypsin suggesting that it was a protein. This protein was in the size range of 30-100 kDa. Thus, fibroblasts could secrete a factor which was able to regulate the expression of MMP-9 in breast cancer cells.

Citing Articles

Migration, invasion, and metastasis are mediated by in neuroblastoma.

Jacobson J, Qiao J, Cochran E, McCreery S, Chung D Front Oncol. 2024; 14:1336031.

PMID: 38884093 PMC: 11176429. DOI: 10.3389/fonc.2024.1336031.

Recruitment and retention: factors that affect pericyte migration.

Aguilera K, Brekken R Cell Mol Life Sci. 2013; 71(2):299-309.

PMID: 23912898 PMC: 3880607. DOI: 10.1007/s00018-013-1432-z.

PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1).

Batra J, Robinson J, Mehner C, Hockla A, Miller E, Radisky D PLoS One. 2012; 7(11):e50028.

PMID: 23185522 PMC: 3502186. DOI: 10.1371/journal.pone.0050028.

Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Mc Donnell S, Chaudhry V, Zeng Z, Shu W, Guillem J Clin Exp Metastasis. 1999; 17(4):341-9.

PMID: 10545021 DOI: 10.1023/a:1006651019335.

Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M Jpn J Cancer Res. 1999; 90(5):516-22.

PMID: 10391091 PMC: 5926108. DOI: 10.1111/j.1349-7006.1999.tb00778.x.

References

Senior R, Griffin G, Fliszar C, Shapiro S, Goldberg G, Welgus H . Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem. 1991; 266(12):7870-5. View

Bernhard E, Hagner B, Wong C, Lubenski I, Muschel R . The effect of E1A transfection on MMP-9 expression and metastatic potential. Int J Cancer. 1995; 60(5):718-24. DOI: 10.1002/ijc.2910600525. View

Ochieng J, Fridman R, Nangia-Makker P, Kleiner D, Liotta L, Stetler-Stevenson W . Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry. 1994; 33(47):14109-14. DOI: 10.1021/bi00251a020. View

Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H . Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun. 1990; 171(2):610-7. DOI: 10.1016/0006-291x(90)91190-4. View

Overall C, Wrana J, Sodek J . Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem. 1989; 264(3):1860-9. View

Noel A, Polette M, Lewalle J, Munaut C, Emonard H, Birembaut P . Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int J Cancer. 1994; 56(3):331-6. DOI: 10.1002/ijc.2910560306. View

Ballin M, Gomez D, Sinha C, Thorgeirsson U . Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun. 1988; 154(3):832-8. DOI: 10.1016/0006-291x(88)90215-x. View

Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T . Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993; 53(22):5365-9. View

Unemori E, Hibbs M, Amento E . Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest. 1991; 88(5):1656-62. PMC: 295696. DOI: 10.1172/JCI115480. View

10.

Welgus H, Campbell E, Cury J, Eisen A, Senior R, Wilhelm S . Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest. 1990; 86(5):1496-502. PMC: 296895. DOI: 10.1172/JCI114867. View

11.

Goustin A, Leof E, Shipley G, Moses H . Growth factors and cancer. Cancer Res. 1986; 46(3):1015-29. View

12.

Pyke C, Ralfkiaer E, Tryggvason K, Dano K . Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 1993; 142(2):359-65. PMC: 1886712. View

13.

Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A, Autio-Harmainen H . 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem. 1994; 42(7):945-51. DOI: 10.1177/42.7.8014478. View

14.

Sato H, Seiki M . Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 1993; 8(2):395-405. View

15.

Fisher S, Cui T, Zhang L, Hartman L, Grahl K, Zhang G . Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol. 1989; 109(2):891-902. PMC: 2115717. DOI: 10.1083/jcb.109.2.891. View

16.

Birkedal-Hansen H, Moore W, Bodden M, Windsor L, DeCarlo A, Engler J . Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993; 4(2):197-250. DOI: 10.1177/10454411930040020401. View

17.

Woessner Jr J . Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5(8):2145-54. View

18.

Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K . Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992; 267(30):21712-9. View

19.

Yamagata S, Ito Y, Tanaka R, Shimizu S . Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun. 1988; 151(1):158-62. DOI: 10.1016/0006-291x(88)90573-6. View

20.

Soini Y, Salo T, Oikarinen A, Autio-Harmainen H . Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas. Lab Invest. 1993; 69(3):305-11. View